Inhibition of FoxO1 was reported to mediate the proliferative and pro‐survival effects of exendin‐4, another GLP‐1 agonist, in insulinoma cells and transgenic mice 55. The gene discussed is FOXO1; the disease is pancreatic insulinoma.